phenytoin has been researched along with Hypertension, Pulmonary in 3 studies
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adesina, SE | 1 |
| Kang, BY | 1 |
| Bijli, KM | 1 |
| Ma, J | 1 |
| Cheng, J | 1 |
| Murphy, TC | 1 |
| Michael Hart, C | 1 |
| Sutliff, RL | 1 |
| Lippmann, M | 1 |
| Whitcomb, ME | 1 |
2 reviews available for phenytoin and Hypertension, Pulmonary
| Article | Year |
|---|---|
Pulmonary reactions to drugs.
Topics: Adrenal Cortex Hormones; Aged; Aminoglycosides; Bleomycin; Busulfan; Contraceptives, Oral; Female; F | 1977 |
Drug-induced lung disease.
Topics: Anti-Bacterial Agents; Anticoagulants; Antihypertensive Agents; Bleomycin; Busulfan; Chlorpropamide; | 1973 |
1 other study available for phenytoin and Hypertension, Pulmonary
| Article | Year |
|---|---|
Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension.
Topics: Animals; Antioxidants; Cell Hypoxia; Cell Proliferation; Endothelial Cells; Humans; Hypertension, Pu | 2015 |